⌘K

Login Start Free

Home/Filings/4/0001181431-10-006616

4//SEC Filing

RAAB G KIRK 4

Accession 0001181431-10-006616

CIK 0001178711other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 1:17 PM ET

Size

5.6 KB

Accession

0001181431-10-006616

Insider Transaction Report

Form 4

Period: 2010-02-03

Transcept Pharmaceuticals IncTSPT

Director

Transactions

Award
Common Stock Option (right to buy)
2010-02-03+17,500→ 17,500 total
Exercise: $8.07Exp: 2020-02-03→ Common Stock (17,500 underlying)

Footnotes (1)

[F1]The option vests in twenty-four equal monthly installments beginning March 3, 2010.

Documents

1 file

4
rrd264916.xmlPrimary
RAAB 2-3-10 AWARD

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

Entity typeother

Related Parties

1

filerCIK 0001210530

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 1:17 PM ET
Size: 5.6 KB

View on SEC.gov